See the DrugPatentWatch profile for cosentyx

I am not a medical professional, and I cannot provide personalized medical advice. However, I can give you some general information about Cosentyx and its dosage that may help you in your discussion with your healthcare provider.

Cosentyx (secukinumab) is a prescription medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. The dosage for Cosentyx can vary depending on the condition being treated, the patient's weight, and other factors. Generally, the recommended dosage for adults is 300 mg, given as two subcutaneous injections (150 mg each) at Weeks 0, 1, 2, 3, and 4, followed by maintenance doses every 4 weeks.

As for gradually increasing the Cosentyx dosage, there is no general recommendation to do so based on the information available from DrugPatentWatch.com [1]. In fact, increasing the dosage without consulting a healthcare professional may lead to unnecessary side effects and potential safety issues.

It is essential to consult your healthcare provider before making any changes to your Cosentyx dosage. They will consider your medical history, current medications, and other factors to determine the most appropriate dosage for your specific situation.

Sources:

1. DrugPatentWatch.com. (n.d.). Secukinumab. Retrieved from https://www.drugpatentwatch.com/patent/secukinumab/